Regulatory Update — Week of July 3, 2023 By PacConAdmin | July 7, 2023 Over the past week, the FDA the FDA has requested comments on a Cardiovascular and Renal Drugs Advisory Committee meeting. Source: Drug Industry Daily Posted in Drug Industry Daily